Clinical Trial Update: Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating combined imaging modalities in pulmonary arterial hypertension using bosentan has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• TRACLEER (bosentan)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: WITHDRAWN